nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Body mass index and risk of Hodgkin's lymphoma: Insights from a Norwegian cohort study
|
Aune, Dagfinn |
|
|
221 |
C |
p. |
artikel |
2 |
Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes
|
Fortuny, Marta |
|
|
221 |
C |
p. |
artikel |
3 |
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients
|
Lodde, Georg C. |
|
|
221 |
C |
p. |
artikel |
4 |
Correlation between irAEs and survival outcomes in patients with ES-SCLC treated with first-line chemoimmunotherapy
|
Monaca, Federico |
|
|
221 |
C |
p. |
artikel |
5 |
Corrigendum to “Implementation of paediatric precision oncology into clinical practice: The individualized therapies for children with cancer program ‘iTHER’” [Eur J Cancer 175 (2022) 311–325]
|
Langenberg, Karin P.S. |
|
|
221 |
C |
p. |
artikel |
6 |
Current perspective on resectability in stage III locally advanced NSCLC – The thoracic surgeons’ view
|
Aigner, Clemens |
|
|
221 |
C |
p. |
artikel |
7 |
Editorial Board
|
|
|
|
221 |
C |
p. |
artikel |
8 |
Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trial
|
Akdogan, Orhun |
|
|
221 |
C |
p. |
artikel |
9 |
Impact of assessment-to-treatment interval and metastatic biopsy site on the predictive value of PD-L1 expression at the 1 % cut-off level in melanoma
|
Vestergaard, Cecilie D. |
|
|
221 |
C |
p. |
artikel |
10 |
Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study
|
Bedard, Philippe L. |
|
|
221 |
C |
p. |
artikel |
11 |
Insights on the association of anthropometric and metabolic variables with tumor features and genomic risk in luminal early breast cancer: Results of a multicentric prospective study
|
De Placido, Pietro |
|
|
221 |
C |
p. |
artikel |
12 |
Letter Re: Association of pregnancy with tumour progression in patients with glioma
|
Dang, Chunxiao |
|
|
221 |
C |
p. |
artikel |
13 |
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer
|
Weiss, Lena |
|
|
221 |
C |
p. |
artikel |
14 |
Pathogenomic fingerprinting to identify associations between tumor morphology and epigenetic states
|
Monabbati, Shayan |
|
|
221 |
C |
p. |
artikel |
15 |
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
|
Tahara, Makoto |
|
|
221 |
C |
p. |
artikel |
16 |
Response to letter commenting on “Association of pregnancy with tumour progression in patients with glioma”
|
Leibetseder, Annette |
|
|
221 |
C |
p. |
artikel |
17 |
The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor
|
Shatila, Malek |
|
|
221 |
C |
p. |
artikel |